[Retracted] Meta-Analysis of the Effectiveness and Safety of Glucocorticoid for the Treatment of IgA Kidney Disease

Table 5

Effect of long-term (≥1 year) course of glucocorticoid on proteinuria in IgA nephropathy.

Glucocorticoid group				Control group			Std. mean difference
Study or subgroup	Mean	SD	Total	Mean	SD	Total	Weight	IV, fixed, 95% CI
Kobayashi et al., 1996	0.8	0.5	20	1.5	1.3	26	15.4%	−0.67 [−1.27,−0.07]
Shoji et al., 2000	0.29	0.23	11	0.71	0.39	8	5.3%	−1.31 [−2.33,−0.29]
Moriyama et al., 2004	1.02	0.98	20	1.28	2.19	40	19.2%	−0.14 [−0.67, 0.40]
Hogg et al., 2006	−1.26	0.56	34	−0.86	0.45	31	21.7%	−0.77 [−1.28, −0.27]
Koike et al., 2008	0.31	0.51	24	0.68	0.69	24	16.5%	−0.60 [−1.18, −0.02]
Lv et al., 2009	−2.5	0.9	33	−2	0.8	30	21.8%	−0.58 [−1.08, −0.07]
Total (95% CI)			142			159	100.0%	−0.59 [−0.83, −0.36]

Heterogeneity: Chi’ = 5.21, df = 5 ( = 0.39); F = 4%. Test for overall effect: Z = 4.92 (＜0.00001).